CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.080
+0.230 (5.97%)
Sep 23, 2026, 12:40 PM EDT - Market open
CollPlant Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.26 | 5.59 | 11.91 | 26.67 | 29.65 | 13.15 |
Short-Term Investments | - | - | - | - | - | 30.15 |
Cash & Short-Term Investments | 4.26 | 5.59 | 11.91 | 26.67 | 29.65 | 43.3 |
Cash Growth | -60.30% | -53.05% | -55.35% | -10.05% | -31.52% | 1199.10% |
Accounts Receivable | 0.01 | 0 | 0.15 | - | 0.01 | 0.27 |
Other Receivables | 0.23 | 0.22 | 0.43 | 0.39 | 0.54 | 0.42 |
Receivables | 0.23 | 0.22 | 0.58 | 0.39 | 0.55 | 0.69 |
Inventory | 0.68 | 0.57 | 0.44 | 0.71 | 1.43 | 1.08 |
Other Current Assets | 0.37 | 0.36 | 0.25 | 0.24 | 0.02 | 0.01 |
Total Current Assets | 5.54 | 6.75 | 13.18 | 28.02 | 31.66 | 45.09 |
Property, Plant & Equipment | 3.51 | 3.89 | 5.28 | 5.86 | 5.68 | 5.68 |
Other Intangible Assets | 0.06 | 0.07 | 0.13 | 0.19 | 0.25 | 0.24 |
Other Long-Term Assets | 0.08 | 0.08 | 0.12 | 0.06 | 0.19 | 0.21 |
Total Assets | 9.18 | 10.79 | 18.71 | 34.13 | 37.77 | 51.22 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.64 | 0.61 | 0.87 | 0.98 | 1.13 | 1.03 |
Accrued Expenses | 1.01 | 1.25 | 1.29 | 1.65 | 1.44 | 1.43 |
Current Portion of Leases | 0.79 | 0.81 | 0.81 | 0.62 | 0.53 | 0.52 |
Current Unearned Revenue | - | - | - | - | - | 0.03 |
Total Current Liabilities | 2.44 | 2.67 | 2.97 | 3.25 | 3.11 | 3.01 |
Long-Term Leases | 1.86 | 2.03 | 2.28 | 2.54 | 2.38 | 3.09 |
Total Liabilities | 4.3 | 4.7 | 5.25 | 5.79 | 5.49 | 6.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 6.27 | 5.49 | 4.98 | 4.98 | 4.87 | 4.66 |
Additional Paid-In Capital | 127.53 | 126.4 | 122.8 | 121.07 | 118.1 | 114.22 |
Retained Earnings | -127.94 | -124.84 | -113.35 | -96.74 | -89.72 | -72.8 |
Comprehensive Income & Other | -0.97 | -0.97 | -0.97 | -0.97 | -0.97 | -0.97 |
Shareholders' Equity | 4.89 | 6.08 | 13.47 | 28.34 | 32.28 | 45.12 |
Total Liabilities & Equity | 9.18 | 10.79 | 18.71 | 34.13 | 37.77 | 51.22 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.65 | 2.85 | 3.08 | 3.16 | 2.91 | 3.61 |
Net Cash (Debt) | 1.61 | 2.75 | 8.83 | 23.52 | 26.74 | 39.69 |
Net Cash Growth | -79.56% | -68.91% | -62.46% | -12.07% | -32.63% | - |
Net Cash Per Share | 1.26 | 2.25 | 7.71 | 20.65 | 24.24 | 33.17 |
Filing Date Shares Outstanding | 1.44 | 1.44 | 1.15 | 1.15 | 1.08 | 1.08 |
Total Common Shares Outstanding | 1.44 | 1.28 | 1.15 | 1.15 | 1.08 | 1.08 |
Working Capital | 3.1 | 4.08 | 10.21 | 24.77 | 28.55 | 42.07 |
Book Value Per Share | 3.39 | 4.75 | 11.76 | 24.75 | 29.97 | 41.89 |
Tangible Book Value | 4.83 | 6.01 | 13.33 | 28.15 | 32.04 | 44.88 |
Tangible Book Value Per Share | 3.35 | 4.69 | 11.64 | 24.58 | 29.74 | 41.66 |
Machinery | - | 5.68 | 5.66 | 5.33 | 4.7 | 4.11 |
Leasehold Improvements | - | 3.66 | 3.65 | 3.5 | 3.31 | 2.63 |